Claims have been seen as the Cinderella of the protection world. But as Karin Lloyd points out, that is about to change

What's the one thing the financial services industry would like to see changed? We asked the question to some of this year's Gold Standard Award winners during a ceremony at the House of Commons.

With take up of sales in income protection (IP) by advisers so low, reflecting in low consumer sales, what could be done to the product to make it more attractive to IFAs, apart from increased commission?

My client has been reading about severity based payments for critical illness (CI) policies. I believe there is merit in polices that don't do this. In sales terms, what is the opposite side of the argument I can put to him?

By way of a Christmas present, the FSA and the OFT are consulting on guidance about new post PPI products, such as short-term IP (STIP).

Bupa's open referral process has attracted criticism. In return, Dr Natalie-Jane Macdonald puts forward the case for Bupa

Lee Robertson, CEO of wealth management firm Investment Quorum, explains why he is still positive on equity markets despite negative sentiment.

On a recent road trip, Shaun Sandiford, business development director at Axa Wealth, asked advisers how they would change their business if RDR didn't exist.

Richard Henry, director of investor solutions at Barclays Wealth, on why current 
market conditions are encouraging for structured products.

It may be an off-market asset class, but Nik Bower, director for Ingenious Investments, argues the film business offers significant opportunities for investors...